Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
来源期刊:OncologyDOI:10.1159/000501281
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib
来源期刊:OncologyDOI:10.1159/000499715
The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma
来源期刊:OncologyDOI:10.1159/000498943
Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma
来源期刊:OncologyDOI:10.1159/000502095
Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening
来源期刊:OncologyDOI:10.1159/000500639
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer
来源期刊:OncologyDOI:10.1159/000495988
Tropomyosin-Related Kinase Receptor and Neurotrophin Expression in Cutaneous Melanoma Is Associated with a Poor Prognosis and Decreased Survival
来源期刊:OncologyDOI:10.1159/000499384
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial
来源期刊:OncologyDOI:10.1159/000499628
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer
来源期刊:OncologyDOI:10.1159/000495989
Dental Cone Beam Computed Tomography in Children: Clinical Effectiveness and Cancer Risk due to Radiation Exposure
来源期刊:OncologyDOI:10.1159/000497059
Use of Complementary and Alternative Medicines among Cancer Patients: A Single-Center Study
来源期刊:OncologyDOI:10.1159/000499629
Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort Study
来源期刊:OncologyDOI:10.1159/000499583
Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1
来源期刊:OncologyDOI:10.1159/000500359
Co-Occurring Symptoms Contribute to Persistent Fatigue in Prostate Cancer
来源期刊:OncologyDOI:10.1159/000494620
Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
来源期刊:OncologyDOI:10.1159/000499569
Cetuximab in Pancreatic Cancer Therapy: A Systematic Review and Meta-Analysis
来源期刊:OncologyDOI:10.1159/000502844
Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors
来源期刊:OncologyDOI:10.1159/000502384
Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma
来源期刊:OncologyDOI:10.1159/000496978
Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer
来源期刊:OncologyDOI:10.1159/000504651
The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy
来源期刊:OncologyDOI:10.1159/000500926
Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy
来源期刊:OncologyDOI:10.1159/000500604
The Evolving Arena of Ovarian Cancer Maintenance Therapy
来源期刊:OncologyDOI:10.1159/000501618
Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint Blockade
来源期刊:OncologyDOI:10.1159/000503566
Local Therapy in Advanced Cholangiocarcinoma: A Review of Current Endoscopic, Medical, and Oncologic Treatment Options
来源期刊:OncologyDOI:10.1159/000500832
Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB
来源期刊:OncologyDOI:10.1159/000503149
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience
来源期刊:OncologyDOI:10.1159/000504578
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302
来源期刊:OncologyDOI:10.1159/000501967
Racial Disparities, Outcomes, and Surgical Utilization among Hispanics with Esophageal Cancer: A Surveillance, Epidemiology, and End Results Program Database Analysis
来源期刊:OncologyDOI:10.1159/000499716
Molecular Barcode Sequencing for Highly Sensitive Detection of Circulating Tumor DNA in Patients with Esophageal Squamous Cell Carcinoma
来源期刊:OncologyDOI:10.1159/000504808
Prophylactic Effect of Premedication with Intravenous Magnesium on Renal Dysfunction in Preoperative Cisplatin-Based Chemotherapy for Esophageal Cancer
来源期刊:OncologyDOI:10.1159/000501966
Trastuzumab Emtansine (T-DM1) Plus S-1 in Patients with Trastuzumab-Pretreated HER2-Positive Advanced or Metastatic Breast Cancer: A Phase Ib Study
来源期刊:OncologyDOI:10.1159/000497276
Expression of c-Met in Primary and Recurrent Hepatocellular Carcinoma
来源期刊:OncologyDOI:10.1159/000504806
Recognition and Treatment of Adrenal Insufficiency Secondary to Abiraterone: A Case Report and Literature Review
来源期刊:OncologyDOI:10.1159/000501640
Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort Study
来源期刊:OncologyDOI:10.1159/000500783
Immuno-Oncological Treatment and Tumor Mass in Non-Small Cell Lung Cancer: Case-Control Analysis of Overall Survival in Routine Clinical Practice
来源期刊:OncologyDOI:10.1159/000500885
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma
来源期刊:OncologyDOI:10.1159/000501398
Risk of Pneumonitis with the Use of Different Immune Checkpoint Inhibitors in a Mexican Population
来源期刊:OncologyDOI:10.1159/000497405
Expressiveness of Bone Markers in Breast Cancer with Bone Metastases
来源期刊:OncologyDOI:10.1159/000500675
Intrahepatic Oxaliplatin and Systemic 5-FU +/– Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer
来源期刊:OncologyDOI:10.1159/000499314
Clinically Node-Negative Parotid Gland Cancers: Prognostic Factors of Survival and Surgical Extent
来源期刊:OncologyDOI:10.1159/000503580
Hemiablation of Localized Prostate Cancer by High-Intensity Focused Ultrasound: A Series of 35 Cases
来源期刊:OncologyDOI:10.1159/000499739
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma
来源期刊:OncologyDOI:10.1159/000504393
Radiographic Assessment of Objective Responses Using the ITMIG-Modified Criteria in Thymic Carcinoma
来源期刊:OncologyDOI:10.1159/000501104
Impact of Cigarette Smoking and Head and Neck Squamous Cell Carcinoma on Circulating Inflammatory Biomarkers
来源期刊:OncologyDOI:10.1159/000502651
Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab
来源期刊:OncologyDOI:10.1159/000502910
A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
来源期刊:OncologyDOI:10.1159/000500677
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen
来源期刊:OncologyDOI:10.1159/000502116
Diffuse Hepatic Infiltration by Metastatic Melanoma.
来源期刊:OncologyDOI:10.46883/onc.2020.3307.0295
Impact of the Type of Analgesic Therapy on Postsurgical Complications of Patients with Kidney Cancer Undergoing Nephrectomy
来源期刊:OncologyDOI:10.1159/000504258
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer
来源期刊:OncologyDOI:10.1159/000500326